Inotiv
CLOSE ×

Infectious disease

Tan T K, Rijal P, Rahikainen R, Keeble A H, Schimanski L, Hussain S, Harvey R, et al., A COVID-19 vaccine candidate using SpyCatcher multimerization of the SARS-CoV-2 spike protein receptor-binding domain induces potent neutralising antibody responses, bioRxiv 2020.08.31.275701; doi: https://doi.org/10.1101/2020.08.31.275701
Ghebremedhin A, Salam AB, Adu-Addai B, Noonan S, Stratton R, Ahmed MSU, Khantwal C, Martin GR, Lin H, Andrews C, Karanam B, Rudloff U, Lopez H, Jaynes J, Yates C., A Novel CD206 Targeting Peptide Inhibits Bleomycin Induced Pulmonary Fibrosis in Mice, bioRxiv. 2020 Jul 29:2020.07.27.218115. doi: 10.1101/2020.07.27.218115. Preprint.
Kelly, S. H., Votaw, N. L., Cossette, B. J., Wu, Y., Shetty, S., Shores, L. S., Issah, L. A., & Collier, J. H., A sublingual nanofiber vaccine to prevent urinary tract infections, Science advances, 8(47), eabq4120. https://doi.org/10.1126/sciadv.abq4120
Vaillant, L., Oster, P., McMillan, B., Orozco Fernandez, E., & Velin, D., GM-CSF is key in the efficacy of vaccine-induced reduction of Helicobacter pylori infection, Helicobacter, 27(2), e12875. https://doi.org/10.1111/hel.12875
Schumann S, Kaiser A, Nicoletti F, Mangano K, Fagone P, van Wijk E, Yan Y, Schulz P, Ludescher B, Niedermaier M, von Wegerer J, Rauch P, Setz C, Schubert U, Brysch W., Immune-Modulating Drug MP1032 with SARS-CoV-2 Antiviral Activity In Vitro: A potential Multi-Target Approach for Prevention and Early Intervention Treatment of COVID-19, Int J Mol Sci. 2020 Nov 20;21(22):8803. doi: 10.3390/ijms21228803.
Stanelle-Bertram, S., Schaumburg, B., Kouassi, N. M., Beck, S., Zickler, M., Beythien, G., ... & dos Reis, V. P., SARS-CoV-2 induced CYP19A1 expression in the lung correlates with increased aromatization of testosterone-to-estradiol in male golden hamsters, Research Square, 20 Nov 2020. DOI: 10.21203/rs.3.rs-107474/v1
Singh V, Beer A, Kraus A, et al., Stroke increases the expression of ACE2, the SARS-CoV-2 binding receptor, in murine lungs, bioRxiv 2020.06.24.162941; doi: https://doi.org/10.1101/2020.06.24.162941
Ye G, Gallant JP, Massey C, Shi K, Tai W, Zheng J, Odle AE, Vickers MA, Shang J, Wan Y, Drelich A, Kempaiah KR, Tat V, Perlman S, Du L, Tseng CT, Aihara H, LeBeau AM, Li F., The Development of a Novel Nanobody Therapeutic for SARS-CoV-2, bioRxiv. 2020 Nov 17:2020.11.17.386532. doi: 10.1101/2020.11.17.386532. Preprint.
Mair I, Bennett AR, Forman R, Othman AA, Logunova L, Smith H, Lowe AE, Bradley JE, Thornton DJ, Else KJ., T. Muris Infection Dynamics of a Fresh, Wild Isolate: Is the Established E Isolate Still Relevant?, Parasite Immunol. 2024 Nov;46(11):e13072. doi: 10.1111/pim.13072.
Graham VA, Easterbrook L, Rayner E, Findlay-Wilson S, Flett L, Kennedy E, Fotheringham S, Kempster S, Almond N, Dowall S., Comparison of Chikungunya Virus-Induced Disease Progression and Pathogenesis in Type-I Interferon Receptor-Deficient Mice (A129) and Two Wild-Type (129Sv/Ev and C57BL/6) Mouse Strains., Viruses. 2024 Sep 27;16(10). doi: 10.3390/v16101534.
Jutzeler KS, Le Clec'h W, Chevalier FD, Anderson TJC., Contribution of parasite and host genotype to immunopathology of schistosome infections., Parasit Vectors. 2024 May 7;17(1):203. doi: 10.1186/s13071-024-06286-6.

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now